<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36836207</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1672</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12041672</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">SARS-CoV-2, responsible for the coronavirus disease (COVID-19) pandemic, may impact other systems apart from the respiratory system, including the nervous system. In this systematic review, we aimed to establish the prevalence and determinants of neuropathic pain amongst COVID-19-infected individuals.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="METHODS">A literature search in the PubMed database was performed and 11 papers were eligible for inclusion in this systematic review and meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The pooled prevalence of COVID-19-related neuropathic pain was 6.7% (95% CI: 4.7-9.5%) for hospitalised patients during the acute phase and 34.3% (95% CI: 14.3-62%) for long COVID patients. The identified risk factors for COVID-19-related neuropathic pain development included depression, COVID-19 severity and azithromycin use.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Neuropathic pain is a very common symptom in long COVID, indicating the urgency for further research in this direction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Laura Dawn</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Medical School, University of Sheffield, Sheffield S10 2RX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zis</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8567-3092</Identifier><AffiliationInfo><Affiliation>Medical School, University of Sheffield, Sheffield S10 2RX, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, University of Cyprus, Nicosia 2029, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Second Department of Neurology, School of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 124 62 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuropathic pain</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>3</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36836207</ArticleId><ArticleId IdType="pmc">PMC9966617</ArticleId><ArticleId IdType="doi">10.3390/jcm12041672</ArticleId><ArticleId IdType="pii">jcm12041672</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baud D., Qi X., Nielsen-Saines K., Musso D., Pomar L., Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect. Dis. 2020;20:773. doi: 10.1016/S1473-3099(20)30195-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30195-X</ArticleId><ArticleId IdType="pmc">PMC7118515</ArticleId><ArticleId IdType="pubmed">32171390</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B., Brady W.J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020;38:1504&#x2013;1507. doi: 10.1016/j.ajem.2020.04.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.04.048</ArticleId><ArticleId IdType="pmc">PMC7165109</ArticleId><ArticleId IdType="pubmed">32317203</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi D., Gyanpuri V., Pathak A., Chaurasia R.N., Mishra V.N., Kumar A., Singh V.K., Dhiman N.R. Neuropathic Pain Associated with COVID-19: A Systematic Review of Case Reports. Curr. Pain Headache Rep. 2022;26:595&#x2013;603. doi: 10.1007/s11916-022-01065-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01065-3</ArticleId><ArticleId IdType="pmc">PMC9214475</ArticleId><ArticleId IdType="pubmed">35731363</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnerup N.B., Kuner R., Jensen T.S. Neuropathic pain: From mechanisms to treatment. Physiol. Rev. 2021;101:259&#x2013;301. doi: 10.1152/physrev.00045.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00045.2019</ArticleId><ArticleId IdType="pubmed">32584191</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister K., Sachau J., Baron R., Dickenson A.H. Neuropathic pain: Mechanism-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 2020;60:257&#x2013;274. doi: 10.1146/annurev-pharmtox-010818-021524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010818-021524</ArticleId><ArticleId IdType="pubmed">31914896</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli E., Mammana S., Nicoletti F., Bramanti P., Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int. J. Immunopathol. Pharmacol. 2019;33:1&#x2013;10. doi: 10.1177/2058738419838383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2058738419838383</ArticleId><ArticleId IdType="pmc">PMC6431761</ArticleId><ArticleId IdType="pubmed">30900486</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaggi A.S., Singh N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology. 2012;291:1&#x2013;9. doi: 10.1016/j.tox.2011.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2011.10.019</ArticleId><ArticleId IdType="pubmed">22079234</ArticleId></ArticleIdList></Reference><Reference><Citation>Mearns E.S., Taylor A., Thomas Craig K.J., Puglielli S., Cichewicz A.B., Leffler D.A., Sanders D.S., Lebwohl B., Hadjivassiliou M. Neurological manifestations of neuropathy and ataxia in celiac disease: A systematic review. Nutrients. 2019;11:380. doi: 10.3390/nu11020380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11020380</ArticleId><ArticleId IdType="pmc">PMC6412791</ArticleId><ArticleId IdType="pubmed">30759885</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Hu Y., Xie K., Chen Y., Wang H., Bian Y., Wang Y., Dong A., Yu Y. Effect of autophagy on allodynia, hyperalgesia and astrocyte activation in a rat model of neuropathic pain. Int. J. Mol. Med. 2018;42:2009&#x2013;2019. doi: 10.3892/ijmm.2018.3763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2018.3763</ArticleId><ArticleId IdType="pmc">PMC6108883</ArticleId><ArticleId IdType="pubmed">30015858</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Bono J., Tao Y.X. Long noncoding RNA (lncRNA): A target in neuropathic pain. Expert Opin. Ther. Targets. 2019;23:15&#x2013;20. doi: 10.1080/14728222.2019.1550075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2019.1550075</ArticleId><ArticleId IdType="pmc">PMC6294120</ArticleId><ArticleId IdType="pubmed">30451044</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkers M., Faber C.G., Hoeijmakers J.G., Lauria G., Merkies I.S. Small fibers, large impact: Quality of life in small-fiber neuropathy. Muscle Nerve. 2014;49:329&#x2013;336. doi: 10.1002/mus.23910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23910</ArticleId><ArticleId IdType="pubmed">23716362</ArticleId></ArticleIdList></Reference><Reference><Citation>Smart K.M., Blake C., Staines A., Doody C. Self-reported pain severity, quality of life, disability, anxiety and depression in patients classified with &#x2018;nociceptive&#x2019;, &#x2018;peripheral neuropathic&#x2019; and &#x2018;central sensitisation&#x2019; pain. The discriminant validity of mechanisms-based classifications of low back (&#xb1;leg) pain. Man. Ther. 2012;17:119&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">22074733</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark A.K., Old E.A., Malcangio M. Neuropathic pain and cytokines: Current perspectives. J. Pain Res. 2013;6:803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839806</ArticleId><ArticleId IdType="pubmed">24294006</ArticleId></ArticleIdList></Reference><Reference><Citation>Attal N., Martinez V., Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep. 2021;6:e884. doi: 10.1097/PR9.0000000000000884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000884</ArticleId><ArticleId IdType="pmc">PMC7850724</ArticleId><ArticleId IdType="pubmed">33537521</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarland A.J., Yousuf M.S., Shiers S., Price T.J. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: Implications for COVID-19 and pain. Pain Rep. 2021;6:e885. doi: 10.1097/PR9.0000000000000885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000885</ArticleId><ArticleId IdType="pmc">PMC7803673</ArticleId><ArticleId IdType="pubmed">33458558</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson W.S., Wilson M.C., Nishikawa J., Hayward R.S. The well-built clinical question: A key to evidence-based decisions. ACP J. Club. 1995;123:A12&#x2013;A13. doi: 10.7326/ACPJC-1995-123-3-A12.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/ACPJC-1995-123-3-A12</ArticleId><ArticleId IdType="pubmed">7582737</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies K.S. Formulating the evidence-based practice question: A review of the frameworks. Evid. Based Libr. Inf. Pract. 2011;6:75&#x2013;80. doi: 10.18438/B8WS5N.</Citation><ArticleIdList><ArticleId IdType="doi">10.18438/B8WS5N</ArticleId></ArticleIdList></Reference><Reference><Citation>Raja S.N., Carr D.B., Cohen M., Finnerup N.B., Flor H., Gibson S., Keefe F., Mogil J.S., Ringkamp M., Sluka K.A., et al. The revised IASP definition of pain: Concepts, challenges, and compromises. Pain. 2020;161:1976. doi: 10.1097/j.pain.0000000000001939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001939</ArticleId><ArticleId IdType="pmc">PMC7680716</ArticleId><ArticleId IdType="pubmed">32694387</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P., Horvath S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. doi: 10.1186/1471-2105-9-559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoy D., Brooks P., Woolf A., Blyth F., March L., Bain C., Baker P., Smith E., Buchbinder R. Assessing risk of bias in prevalence studies: Modification of an existing tool and evidence of interrater agreement. J. Clin. Epidemiol. 2012;65:934&#x2013;939. doi: 10.1016/j.jclinepi.2011.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.11.014</ArticleId><ArticleId IdType="pubmed">22742910</ArticleId></ArticleIdList></Reference><Reference><Citation>Liampas A., Velidakis N., Georgiou T., Vadalouca A., Varrassi G., Hadjigeorgiou G.M., Tsivgoulis G., Zis P. Prevalence and management challenges in central post-stroke neuropathic pain: A systematic review and meta-analysis. Adv. Ther. 2020;37:3278&#x2013;3291. doi: 10.1007/s12325-020-01388-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-020-01388-w</ArticleId><ArticleId IdType="pmc">PMC7467424</ArticleId><ArticleId IdType="pubmed">32451951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali S.T., Kang A.K., Patel T.R., Clark J.R., Perez-Giraldo G.S., Orban Z.S., Lim P.H., Jimenez M., Graham E.L., Batra A., et al. Evolution of neurologic symptoms in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2022;9:950&#x2013;961. doi: 10.1002/acn3.51570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51570</ArticleId><ArticleId IdType="pmc">PMC9268866</ArticleId><ArticleId IdType="pubmed">35607826</ArticleId></ArticleIdList></Reference><Reference><Citation>Jena D., Sahoo J., Barman A., Gupta A., Patel V. Musculoskeletal and Neurological Pain Symptoms Among Hospitalized COVID-19 Patients. Am. J. Phys. Med. Rehabil. 2022;101:411&#x2013;416. doi: 10.1097/PHM.0000000000001969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001969</ArticleId><ArticleId IdType="pmc">PMC9005090</ArticleId><ArticleId IdType="pubmed">35067551</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller C., O&#x2019;Sullivan J., Jeffrey J., Power D. Brachial Plexus Neuropathies during the COVID-19 Pandemic: A Retrospective Case Series of 15 Patients in Critical Care. Phys. Ther. 2021;101:pzaa191. doi: 10.1093/ptj/pzaa191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzaa191</ArticleId><ArticleId IdType="pmc">PMC7665709</ArticleId><ArticleId IdType="pubmed">33395478</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P., Mukerji S.S., Alabsi H.S., Systrom D., Marciano S.P., Felsenstein D., Mullally W.J., Pilgrim D.M. Multisystem Involvement in Post-Acute Sequelae of Coronavirus Disease 19. Ann. Neurol. 2022;91:367&#x2013;379. doi: 10.1002/ana.26286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26286</ArticleId><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocak O., Sahin E.M. Evaluation of Neuropathic Pain Features in COVID-19 Patients. Neurol. India. 2022;70:591.</Citation><ArticleIdList><ArticleId IdType="pubmed">35532624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojeda A., Calvo A., Cu&#xf1;at T., Mellado-Artigas R., Comino-Trinidad O., Aliaga J., Arias M., Ferrando C., Martinez-Pall&#xed; G., D&#xfc;rsteler C. Characteristics and influence on quality of life of new-onset pain in critical COVID-19 survivors. Eur. J. Pain. 2022;26:680&#x2013;694. doi: 10.1002/ejp.1897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1897</ArticleId><ArticleId IdType="pmc">PMC9015597</ArticleId><ArticleId IdType="pubmed">34866276</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Felten R., Gallais F., Nazon C., Chatelus E., Pijnenburg L., Mengin A., Gras A., Vidailhet P., Arnould-Michel R., et al. Refining &#x201c;Long-COVID&#x201d; by a prospective multimodal evaluation of patients with long-term symptoms attributed to SARS-CoV-2 infection. Infect. Dis. Ther. 2021;10:1747&#x2013;1763. doi: 10.1007/s40121-021-00484-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-021-00484-w</ArticleId><ArticleId IdType="pmc">PMC8270770</ArticleId><ArticleId IdType="pubmed">34245450</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., Suarez M.D., Shelly S., Lamotte G.J., Sandroni P., Benarroch E.E., Berini S.E., Cutsforth-Gregory J.K., et al. Autonomic dysfunction following COVID-19 infection: An early experience. Clin. Auton. Res. 2021;31:385&#x2013;394. doi: 10.1007/s10286-021-00803-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdy R., Eid R.A., Fathy W., Abdel-Aziz M.M., Ibrahim R.E., Yehia A., Sheemy M.S., Hussein M. Characteristics and risk factors of persistent neuropathic pain in recovered COVID-19 patients. Pain Med. 2022;23:774&#x2013;781. doi: 10.1093/pm/pnab341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pm/pnab341</ArticleId><ArticleId IdType="pmc">PMC8755258</ArticleId><ArticleId IdType="pubmed">34931670</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguz-Akarsu E., Gullu G., Kilic E., Dinc Y., Ursavas A., Yilmaz E., Zarifoglu M., Karli N., Pandemic Study Team. Akal&#x131;n H., et al. Insight into pain syndromes in acute phase of mild-to-moderate COVID-19: Frequency, clinical characteristics, and associated factors. Eur. J. Pain. 2022;26:492&#x2013;504. doi: 10.1002/ejp.1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1876</ArticleId><ArticleId IdType="pmc">PMC8653127</ArticleId><ArticleId IdType="pubmed">34622527</ArticleId></ArticleIdList></Reference><Reference><Citation>Starace M., Iorizzo M., Sechi A., Alessandrini A.M., Carpanese M., Bruni F., Vara G., Apalla Z., Asz-Sigall D., Barruscotti S., et al. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management. JAAD Int. 2021;5:11&#x2013;18. doi: 10.1016/j.jdin.2021.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdin.2021.07.006</ArticleId><ArticleId IdType="pmc">PMC8328568</ArticleId><ArticleId IdType="pubmed">34368790</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Dowd A. COVID-19: Third of people infected have long term symptoms. BMJ Br. Med. J. 2021;373:n1626. doi: 10.1136/bmj.n1626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1626</ArticleId><ArticleId IdType="pubmed">34168002</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>